Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab
Geun‐Ho Park, Sehhoon Park, H. Kim, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon Lee
Topics & Concepts
Hazard ratioInternal medicineMedicineLung cancerOncologyBiomarkerProspective cohort studyConcomitantProgression-free survivalProportional hazards modelOverall survivalConfidence intervalBiologyBiochemistryLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchLung Cancer Research Studies